Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCo-Diagnostics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$3.75 | -$3.75 | -$3.75 |
| Q2 2026 | 1 | -$3.00 | -$3.00 | -$3.00 |
| Q3 2026 | 1 | -$1.25 | -$1.25 | -$1.25 |
| Q4 2026 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q1 2027 | 1 | -$0.87 | -$0.87 | -$0.87 |
| Q2 2027 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q3 2027 | 1 | -$0.98 | -$0.98 | -$0.98 |
| Q4 2027 | 1 | -$1.22 | -$1.22 | -$1.22 |
| Q1 2028 | 1 | $4.73 | $4.73 | $4.73 |
| Q2 2028 | 1 | $4.91 | $4.91 | $4.91 |
| Q3 2028 | 1 | $4.81 | $4.81 | $4.81 |
| Q4 2028 | 1 | $4.80 | $4.80 | $4.80 |
Co-Diagnostics Inc Earnings Date And Information
Co-Diagnostics Inc last posted its earnings results on Thursday, August 13th, 2026. The company reported $-1.46 earnings per share for the quarter, topping analysts' consensus estimates of $-3 by $1.54. The company had revenue of 166.13 K for the quarter and had revenue of 622.49 K for the year. Co-Diagnostics Inc has generated $-35 earnings per share over the last year ($-35.25 diluted earnings per share) and currently has a price-to-earnings ratio of -0.04. Co-Diagnostics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Co-Diagnostics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2026 | Q2 2026 | -$3.00 | -$1.46 | 1.54 | $132.58 K | $166.13 K |
| 05/14/2026 | Q1 2026 | -$3.75 | -$4.06 | -0.31 | $127.05 K | $145.95 K |
| 03/31/2026 | Q4 2025 | -$3.60 | -$16.54 | -12.94 | $125.88 K | $263.92 K |
| 11/13/2025 | Q3 2025 | -$5.71 | -$4.66 | 1.05 | $300.00 K | $145.38 K |
| 08/14/2025 | Q2 2025 | -$7.51 | -$7.00 | 0.51 | $300.00 K | $162.91 K |
| 05/08/2025 | Q1 2025 | -$8.10 | -$7.05 | 1.05 | $200.00 K | $50.28 K |
| 03/27/2025 | Q4 2024 | -$0.33 | -$10.01 | -9.68 | $375.00 K | $149.33 K |
| 11/07/2024 | Q3 2024 | -$9.91 | -$9.54 | 0.37 | $375.00 K | $641.14 K |
| 08/08/2024 | Q2 2024 | -$10.21 | -$7.57 | 2.64 | $400.00 K | $2.66 M |
| 05/09/2024 | Q1 2024 | -$6.31 | -$9.36 | -3.05 | $3.10 M | $252.75 K |
| 03/14/2024 | Q4 2023 | -$0.20 | -$14.10 | -13.9 | $3.63 M | $3.56 M |
| 11/09/2023 | Q3 2023 | N/A | -$6.11 | N/A | $200.00 K | $2.46 M |
| 08/10/2023 | Q2 2023 | -$0.24 | -$9.20 | -8.96 | $500.00 K | $197.81 K |
| 05/11/2023 | Q1 2023 | -$0.23 | -$5.86 | -5.64 | $1.10 M | $601.96 K |
| 03/16/2023 | Q4 2022 | -$0.15 | -$21.30 | -21.15 | $5.50 M | $1.40 M |
| 11/10/2022 | Q3 2022 | -$0.06 | -$1.31 | -1.25 | $7.48 M | $5.09 M |
| 08/11/2022 | Q2 2022 | $0.10 | -$2.48 | -2.58 | $15.34 M | $5.02 M |
| 05/12/2022 | Q1 2022 | $5.20 | $10.36 | 5.16 | $21.17 M | $22.70 M |
| 03/24/2022 | Q4 2021 | $3.60 | $7.80 | 4.2 | $20.93 M | $20.40 M |
| 11/12/2021 | Q3 2021 | N/A | $11.90 | N/A | $24.32 M | $30.10 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Co-Diagnostics Inc Earnings: FAQ's
In the previous quarter, Co-Diagnostics Inc (:CODX) reported $-1.46 earnings per share (EPS) to beat the analysts' consensus estimate of $-3 by $1.54.
The conference call for Co-Diagnostics Inc's latest earnings report can be listened to online.
The conference call transcript for Co-Diagnostics Inc's latest earnings report can be read online.
Co-Diagnostics Inc (:CODX) has a recorded annual revenue of $622.49 K.
Co-Diagnostics Inc (:CODX) has a recorded net income of $-46,895,936.Co-Diagnostics Inc has generated $-35.25 earnings per share over the last four quarters.
Co-Diagnostics Inc (:CODX) has a price-to-earnings ratio of -0.04 and price/earnings-to-growth ratio is -0.